nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—CYP1A2—Estropipate—osteoporosis	0.128	0.192	CbGbCtD
Cyclobenzaprine—CYP3A4—Estropipate—osteoporosis	0.0669	0.101	CbGbCtD
Cyclobenzaprine—CYP3A4—Calcitriol—osteoporosis	0.0669	0.101	CbGbCtD
Cyclobenzaprine—CYP1A2—Conjugated Estrogens—osteoporosis	0.0604	0.0909	CbGbCtD
Cyclobenzaprine—CYP2D6—Cholecalciferol—osteoporosis	0.0542	0.0816	CbGbCtD
Cyclobenzaprine—CYP3A4—Ergocalciferol—osteoporosis	0.0535	0.0805	CbGbCtD
Cyclobenzaprine—CYP1A2—Estradiol—osteoporosis	0.053	0.0798	CbGbCtD
Cyclobenzaprine—CYP3A4—Raloxifene—osteoporosis	0.0447	0.0672	CbGbCtD
Cyclobenzaprine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0431	0.0649	CbGbCtD
Cyclobenzaprine—CYP3A4—Cholecalciferol—osteoporosis	0.0345	0.0519	CbGbCtD
Cyclobenzaprine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0317	0.0476	CbGbCtD
Cyclobenzaprine—CYP3A4—Estradiol—osteoporosis	0.0278	0.0418	CbGbCtD
Cyclobenzaprine—Anaphylactic shock—Pamidronate—osteoporosis	0.000443	0.00132	CcSEcCtD
Cyclobenzaprine—Urticaria—Calcitriol—osteoporosis	0.000439	0.00131	CcSEcCtD
Cyclobenzaprine—Hepatitis—Estradiol—osteoporosis	0.000439	0.00131	CcSEcCtD
Cyclobenzaprine—Palpitations—Zoledronate—osteoporosis	0.000438	0.00131	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Calcitriol—osteoporosis	0.000437	0.00131	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Estradiol—osteoporosis	0.000436	0.0013	CcSEcCtD
Cyclobenzaprine—Angioedema—Conjugated Estrogens—osteoporosis	0.000436	0.0013	CcSEcCtD
Cyclobenzaprine—Shock—Pamidronate—osteoporosis	0.000435	0.0013	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Zoledronate—osteoporosis	0.000435	0.0013	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Estradiol—osteoporosis	0.000435	0.0013	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Estropipate—osteoporosis	0.000434	0.0013	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Pamidronate—osteoporosis	0.000433	0.00129	CcSEcCtD
Cyclobenzaprine—Vomiting—Etidronic acid—osteoporosis	0.000433	0.00129	CcSEcCtD
Cyclobenzaprine—Tachycardia—Pamidronate—osteoporosis	0.000432	0.00129	CcSEcCtD
Cyclobenzaprine—Rash—Etidronic acid—osteoporosis	0.000429	0.00128	CcSEcCtD
Cyclobenzaprine—Convulsion—Zoledronate—osteoporosis	0.000429	0.00128	CcSEcCtD
Cyclobenzaprine—Dermatitis—Etidronic acid—osteoporosis	0.000429	0.00128	CcSEcCtD
Cyclobenzaprine—Vertigo—Conjugated Estrogens—osteoporosis	0.000429	0.00128	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Pamidronate—osteoporosis	0.000428	0.00128	CcSEcCtD
Cyclobenzaprine—Syncope—Conjugated Estrogens—osteoporosis	0.000428	0.00128	CcSEcCtD
Cyclobenzaprine—Hypertension—Zoledronate—osteoporosis	0.000428	0.00128	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Alendronate—osteoporosis	0.000428	0.00128	CcSEcCtD
Cyclobenzaprine—Headache—Etidronic acid—osteoporosis	0.000427	0.00127	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000424	0.00127	CcSEcCtD
Cyclobenzaprine—Asthenia—Estropipate—osteoporosis	0.000423	0.00126	CcSEcCtD
Cyclobenzaprine—Anorexia—Pamidronate—osteoporosis	0.000422	0.00126	CcSEcCtD
Cyclobenzaprine—Chest pain—Zoledronate—osteoporosis	0.000422	0.00126	CcSEcCtD
Cyclobenzaprine—Myalgia—Zoledronate—osteoporosis	0.000422	0.00126	CcSEcCtD
Cyclobenzaprine—Palpitations—Conjugated Estrogens—osteoporosis	0.000422	0.00126	CcSEcCtD
Cyclobenzaprine—Insomnia—Risedronate—osteoporosis	0.000421	0.00126	CcSEcCtD
Cyclobenzaprine—Anxiety—Zoledronate—osteoporosis	0.00042	0.00125	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000419	0.00125	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Risedronate—osteoporosis	0.000418	0.00125	CcSEcCtD
Cyclobenzaprine—Pruritus—Estropipate—osteoporosis	0.000417	0.00124	CcSEcCtD
Cyclobenzaprine—Discomfort—Zoledronate—osteoporosis	0.000417	0.00124	CcSEcCtD
Cyclobenzaprine—Asthenia—Alendronate—osteoporosis	0.000416	0.00124	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Ibandronate—osteoporosis	0.000416	0.00124	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Risedronate—osteoporosis	0.000415	0.00124	CcSEcCtD
Cyclobenzaprine—Hypotension—Pamidronate—osteoporosis	0.000414	0.00123	CcSEcCtD
Cyclobenzaprine—Convulsion—Conjugated Estrogens—osteoporosis	0.000413	0.00123	CcSEcCtD
Cyclobenzaprine—Dry mouth—Zoledronate—osteoporosis	0.000412	0.00123	CcSEcCtD
Cyclobenzaprine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000412	0.00123	CcSEcCtD
Cyclobenzaprine—Pruritus—Alendronate—osteoporosis	0.000411	0.00123	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Risedronate—osteoporosis	0.00041	0.00122	CcSEcCtD
Cyclobenzaprine—Tinnitus—Estradiol—osteoporosis	0.000409	0.00122	CcSEcCtD
Cyclobenzaprine—Constipation—Ethinyl Estradiol—osteoporosis	0.000408	0.00122	CcSEcCtD
Cyclobenzaprine—Confusional state—Zoledronate—osteoporosis	0.000408	0.00122	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Calcitriol—osteoporosis	0.000407	0.00122	CcSEcCtD
Cyclobenzaprine—Chest pain—Conjugated Estrogens—osteoporosis	0.000406	0.00121	CcSEcCtD
Cyclobenzaprine—Myalgia—Conjugated Estrogens—osteoporosis	0.000406	0.00121	CcSEcCtD
Cyclobenzaprine—Asthenia—Ibandronate—osteoporosis	0.000405	0.00121	CcSEcCtD
Cyclobenzaprine—Anxiety—Conjugated Estrogens—osteoporosis	0.000405	0.00121	CcSEcCtD
Cyclobenzaprine—Nausea—Etidronic acid—osteoporosis	0.000405	0.00121	CcSEcCtD
Cyclobenzaprine—Oedema—Zoledronate—osteoporosis	0.000404	0.00121	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Zoledronate—osteoporosis	0.000404	0.00121	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000403	0.0012	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Estropipate—osteoporosis	0.000403	0.0012	CcSEcCtD
Cyclobenzaprine—Fatigue—Risedronate—osteoporosis	0.000401	0.0012	CcSEcCtD
Cyclobenzaprine—Insomnia—Pamidronate—osteoporosis	0.0004	0.00119	CcSEcCtD
Cyclobenzaprine—Pruritus—Ibandronate—osteoporosis	0.0004	0.00119	CcSEcCtD
Cyclobenzaprine—Constipation—Risedronate—osteoporosis	0.000398	0.00119	CcSEcCtD
Cyclobenzaprine—Shock—Zoledronate—osteoporosis	0.000398	0.00119	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Pamidronate—osteoporosis	0.000397	0.00119	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Alendronate—osteoporosis	0.000397	0.00119	CcSEcCtD
Cyclobenzaprine—Asthenia—Calcitriol—osteoporosis	0.000397	0.00118	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Zoledronate—osteoporosis	0.000396	0.00118	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Pamidronate—osteoporosis	0.000395	0.00118	CcSEcCtD
Cyclobenzaprine—Tachycardia—Zoledronate—osteoporosis	0.000395	0.00118	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000394	0.00117	CcSEcCtD
Cyclobenzaprine—Somnolence—Pamidronate—osteoporosis	0.000393	0.00117	CcSEcCtD
Cyclobenzaprine—Pruritus—Calcitriol—osteoporosis	0.000391	0.00117	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Zoledronate—osteoporosis	0.000391	0.00117	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000391	0.00117	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Raloxifene—osteoporosis	0.00039	0.00117	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Pamidronate—osteoporosis	0.00039	0.00116	CcSEcCtD
Cyclobenzaprine—Dizziness—Estropipate—osteoporosis	0.00039	0.00116	CcSEcCtD
Cyclobenzaprine—Oedema—Conjugated Estrogens—osteoporosis	0.000389	0.00116	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000389	0.00116	CcSEcCtD
Cyclobenzaprine—Alopecia—Estradiol—osteoporosis	0.000388	0.00116	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Ibandronate—osteoporosis	0.000387	0.00115	CcSEcCtD
Cyclobenzaprine—Anorexia—Zoledronate—osteoporosis	0.000385	0.00115	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Pamidronate—osteoporosis	0.000385	0.00115	CcSEcCtD
Cyclobenzaprine—Dizziness—Alendronate—osteoporosis	0.000384	0.00115	CcSEcCtD
Cyclobenzaprine—Shock—Conjugated Estrogens—osteoporosis	0.000383	0.00114	CcSEcCtD
Cyclobenzaprine—Fatigue—Pamidronate—osteoporosis	0.000382	0.00114	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Risedronate—osteoporosis	0.000381	0.00114	CcSEcCtD
Cyclobenzaprine—Tachycardia—Conjugated Estrogens—osteoporosis	0.00038	0.00113	CcSEcCtD
Cyclobenzaprine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000379	0.00113	CcSEcCtD
Cyclobenzaprine—Constipation—Pamidronate—osteoporosis	0.000379	0.00113	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Calcitriol—osteoporosis	0.000378	0.00113	CcSEcCtD
Cyclobenzaprine—Hypotension—Zoledronate—osteoporosis	0.000378	0.00113	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000378	0.00113	CcSEcCtD
Cyclobenzaprine—Dizziness—Raloxifene—osteoporosis	0.000377	0.00113	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000376	0.00112	CcSEcCtD
Cyclobenzaprine—Flatulence—Estradiol—osteoporosis	0.000376	0.00112	CcSEcCtD
Cyclobenzaprine—Tension—Estradiol—osteoporosis	0.000375	0.00112	CcSEcCtD
Cyclobenzaprine—Vomiting—Estropipate—osteoporosis	0.000375	0.00112	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Estradiol—osteoporosis	0.000374	0.00112	CcSEcCtD
Cyclobenzaprine—Dizziness—Ibandronate—osteoporosis	0.000374	0.00112	CcSEcCtD
Cyclobenzaprine—Rash—Estropipate—osteoporosis	0.000371	0.00111	CcSEcCtD
Cyclobenzaprine—Dermatitis—Estropipate—osteoporosis	0.000371	0.00111	CcSEcCtD
Cyclobenzaprine—Anorexia—Conjugated Estrogens—osteoporosis	0.000371	0.00111	CcSEcCtD
Cyclobenzaprine—Nervousness—Estradiol—osteoporosis	0.000371	0.00111	CcSEcCtD
Cyclobenzaprine—Urticaria—Risedronate—osteoporosis	0.00037	0.0011	CcSEcCtD
Cyclobenzaprine—Headache—Estropipate—osteoporosis	0.000369	0.0011	CcSEcCtD
Cyclobenzaprine—Vomiting—Alendronate—osteoporosis	0.000369	0.0011	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000368	0.0011	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Risedronate—osteoporosis	0.000368	0.0011	CcSEcCtD
Cyclobenzaprine—Rash—Alendronate—osteoporosis	0.000366	0.00109	CcSEcCtD
Cyclobenzaprine—Insomnia—Zoledronate—osteoporosis	0.000366	0.00109	CcSEcCtD
Cyclobenzaprine—Dermatitis—Alendronate—osteoporosis	0.000366	0.00109	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Pamidronate—osteoporosis	0.000365	0.00109	CcSEcCtD
Cyclobenzaprine—Hypotension—Conjugated Estrogens—osteoporosis	0.000364	0.00109	CcSEcCtD
Cyclobenzaprine—Headache—Alendronate—osteoporosis	0.000364	0.00109	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Zoledronate—osteoporosis	0.000363	0.00108	CcSEcCtD
Cyclobenzaprine—Vomiting—Raloxifene—osteoporosis	0.000363	0.00108	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000362	0.00108	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Zoledronate—osteoporosis	0.00036	0.00108	CcSEcCtD
Cyclobenzaprine—Rash—Raloxifene—osteoporosis	0.00036	0.00107	CcSEcCtD
Cyclobenzaprine—Dermatitis—Raloxifene—osteoporosis	0.00036	0.00107	CcSEcCtD
Cyclobenzaprine—Somnolence—Zoledronate—osteoporosis	0.000359	0.00107	CcSEcCtD
Cyclobenzaprine—Vomiting—Ibandronate—osteoporosis	0.000359	0.00107	CcSEcCtD
Cyclobenzaprine—Tremor—Estradiol—osteoporosis	0.000358	0.00107	CcSEcCtD
Cyclobenzaprine—Headache—Raloxifene—osteoporosis	0.000358	0.00107	CcSEcCtD
Cyclobenzaprine—Rash—Ibandronate—osteoporosis	0.000356	0.00106	CcSEcCtD
Cyclobenzaprine—Dermatitis—Ibandronate—osteoporosis	0.000356	0.00106	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Zoledronate—osteoporosis	0.000356	0.00106	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000355	0.00106	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Estradiol—osteoporosis	0.000354	0.00106	CcSEcCtD
Cyclobenzaprine—Headache—Ibandronate—osteoporosis	0.000354	0.00106	CcSEcCtD
Cyclobenzaprine—Insomnia—Conjugated Estrogens—osteoporosis	0.000352	0.00105	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000352	0.00105	CcSEcCtD
Cyclobenzaprine—Vomiting—Calcitriol—osteoporosis	0.000352	0.00105	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Zoledronate—osteoporosis	0.000351	0.00105	CcSEcCtD
Cyclobenzaprine—Agitation—Estradiol—osteoporosis	0.000351	0.00105	CcSEcCtD
Cyclobenzaprine—Nausea—Estropipate—osteoporosis	0.00035	0.00104	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Pamidronate—osteoporosis	0.00035	0.00104	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00035	0.00104	CcSEcCtD
Cyclobenzaprine—Angioedema—Estradiol—osteoporosis	0.000349	0.00104	CcSEcCtD
Cyclobenzaprine—Rash—Calcitriol—osteoporosis	0.000349	0.00104	CcSEcCtD
Cyclobenzaprine—Fatigue—Zoledronate—osteoporosis	0.000349	0.00104	CcSEcCtD
Cyclobenzaprine—Dermatitis—Calcitriol—osteoporosis	0.000348	0.00104	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000347	0.00104	CcSEcCtD
Cyclobenzaprine—Headache—Calcitriol—osteoporosis	0.000346	0.00103	CcSEcCtD
Cyclobenzaprine—Somnolence—Conjugated Estrogens—osteoporosis	0.000346	0.00103	CcSEcCtD
Cyclobenzaprine—Constipation—Zoledronate—osteoporosis	0.000346	0.00103	CcSEcCtD
Cyclobenzaprine—Nausea—Alendronate—osteoporosis	0.000345	0.00103	CcSEcCtD
Cyclobenzaprine—Malaise—Estradiol—osteoporosis	0.000344	0.00103	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Risedronate—osteoporosis	0.000343	0.00102	CcSEcCtD
Cyclobenzaprine—Vertigo—Estradiol—osteoporosis	0.000343	0.00102	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000343	0.00102	CcSEcCtD
Cyclobenzaprine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000343	0.00102	CcSEcCtD
Cyclobenzaprine—Syncope—Estradiol—osteoporosis	0.000342	0.00102	CcSEcCtD
Cyclobenzaprine—Nausea—Raloxifene—osteoporosis	0.000339	0.00101	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000338	0.00101	CcSEcCtD
Cyclobenzaprine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000338	0.00101	CcSEcCtD
Cyclobenzaprine—Palpitations—Estradiol—osteoporosis	0.000337	0.00101	CcSEcCtD
Cyclobenzaprine—Fatigue—Conjugated Estrogens—osteoporosis	0.000336	0.001	CcSEcCtD
Cyclobenzaprine—Nausea—Ibandronate—osteoporosis	0.000336	0.001	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Estradiol—osteoporosis	0.000336	0.001	CcSEcCtD
Cyclobenzaprine—Asthenia—Risedronate—osteoporosis	0.000334	0.000997	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Zoledronate—osteoporosis	0.000333	0.000994	CcSEcCtD
Cyclobenzaprine—Constipation—Conjugated Estrogens—osteoporosis	0.000333	0.000994	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000331	0.000987	CcSEcCtD
Cyclobenzaprine—Hypertension—Estradiol—osteoporosis	0.00033	0.000984	CcSEcCtD
Cyclobenzaprine—Pruritus—Risedronate—osteoporosis	0.000329	0.000983	CcSEcCtD
Cyclobenzaprine—Nausea—Calcitriol—osteoporosis	0.000329	0.000981	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000327	0.000975	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Pamidronate—osteoporosis	0.000326	0.000973	CcSEcCtD
Cyclobenzaprine—Chest pain—Estradiol—osteoporosis	0.000325	0.00097	CcSEcCtD
Cyclobenzaprine—Myalgia—Estradiol—osteoporosis	0.000325	0.00097	CcSEcCtD
Cyclobenzaprine—Anxiety—Estradiol—osteoporosis	0.000324	0.000967	CcSEcCtD
Cyclobenzaprine—Urticaria—Zoledronate—osteoporosis	0.000321	0.000959	CcSEcCtD
Cyclobenzaprine—Discomfort—Estradiol—osteoporosis	0.000321	0.000959	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Zoledronate—osteoporosis	0.00032	0.000954	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Risedronate—osteoporosis	0.000319	0.000951	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000318	0.00095	CcSEcCtD
Cyclobenzaprine—Dry mouth—Estradiol—osteoporosis	0.000318	0.000949	CcSEcCtD
Cyclobenzaprine—Asthenia—Pamidronate—osteoporosis	0.000318	0.000948	CcSEcCtD
Cyclobenzaprine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000316	0.000943	CcSEcCtD
Cyclobenzaprine—Confusional state—Estradiol—osteoporosis	0.000314	0.000938	CcSEcCtD
Cyclobenzaprine—Pruritus—Pamidronate—osteoporosis	0.000313	0.000935	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Estradiol—osteoporosis	0.000312	0.00093	CcSEcCtD
Cyclobenzaprine—Oedema—Estradiol—osteoporosis	0.000312	0.00093	CcSEcCtD
Cyclobenzaprine—Urticaria—Conjugated Estrogens—osteoporosis	0.000309	0.000923	CcSEcCtD
Cyclobenzaprine—Dizziness—Risedronate—osteoporosis	0.000308	0.000919	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000308	0.000919	CcSEcCtD
Cyclobenzaprine—Shock—Estradiol—osteoporosis	0.000307	0.000915	CcSEcCtD
Cyclobenzaprine—Tachycardia—Estradiol—osteoporosis	0.000304	0.000908	CcSEcCtD
Cyclobenzaprine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000304	0.000906	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Pamidronate—osteoporosis	0.000303	0.000904	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Estradiol—osteoporosis	0.000301	0.000899	CcSEcCtD
Cyclobenzaprine—Rash—Ethinyl Estradiol—osteoporosis	0.000301	0.000899	CcSEcCtD
Cyclobenzaprine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000301	0.000898	CcSEcCtD
Cyclobenzaprine—Headache—Ethinyl Estradiol—osteoporosis	0.000299	0.000893	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Zoledronate—osteoporosis	0.000298	0.000889	CcSEcCtD
Cyclobenzaprine—Vomiting—Risedronate—osteoporosis	0.000296	0.000884	CcSEcCtD
Cyclobenzaprine—Rash—Risedronate—osteoporosis	0.000294	0.000876	CcSEcCtD
Cyclobenzaprine—Dermatitis—Risedronate—osteoporosis	0.000293	0.000876	CcSEcCtD
Cyclobenzaprine—Dizziness—Pamidronate—osteoporosis	0.000293	0.000874	CcSEcCtD
Cyclobenzaprine—Headache—Risedronate—osteoporosis	0.000292	0.000871	CcSEcCtD
Cyclobenzaprine—Asthenia—Zoledronate—osteoporosis	0.00029	0.000866	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000287	0.000856	CcSEcCtD
Cyclobenzaprine—Pruritus—Zoledronate—osteoporosis	0.000286	0.000854	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000284	0.000847	CcSEcCtD
Cyclobenzaprine—Nausea—Ethinyl Estradiol—osteoporosis	0.000284	0.000847	CcSEcCtD
Cyclobenzaprine—Insomnia—Estradiol—osteoporosis	0.000282	0.000841	CcSEcCtD
Cyclobenzaprine—Vomiting—Pamidronate—osteoporosis	0.000281	0.00084	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Estradiol—osteoporosis	0.00028	0.000835	CcSEcCtD
Cyclobenzaprine—Asthenia—Conjugated Estrogens—osteoporosis	0.000279	0.000834	CcSEcCtD
Cyclobenzaprine—Rash—Pamidronate—osteoporosis	0.000279	0.000833	CcSEcCtD
Cyclobenzaprine—Dermatitis—Pamidronate—osteoporosis	0.000279	0.000832	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Estradiol—osteoporosis	0.000278	0.000829	CcSEcCtD
Cyclobenzaprine—Headache—Pamidronate—osteoporosis	0.000277	0.000828	CcSEcCtD
Cyclobenzaprine—Somnolence—Estradiol—osteoporosis	0.000277	0.000827	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Zoledronate—osteoporosis	0.000277	0.000826	CcSEcCtD
Cyclobenzaprine—Nausea—Risedronate—osteoporosis	0.000277	0.000826	CcSEcCtD
Cyclobenzaprine—Pruritus—Conjugated Estrogens—osteoporosis	0.000275	0.000822	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Estradiol—osteoporosis	0.000274	0.000819	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Estradiol—osteoporosis	0.000271	0.000808	CcSEcCtD
Cyclobenzaprine—Fatigue—Estradiol—osteoporosis	0.000269	0.000802	CcSEcCtD
Cyclobenzaprine—Dizziness—Zoledronate—osteoporosis	0.000267	0.000798	CcSEcCtD
Cyclobenzaprine—Constipation—Estradiol—osteoporosis	0.000266	0.000795	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000266	0.000795	CcSEcCtD
Cyclobenzaprine—Nausea—Pamidronate—osteoporosis	0.000263	0.000785	CcSEcCtD
Cyclobenzaprine—Dizziness—Conjugated Estrogens—osteoporosis	0.000257	0.000768	CcSEcCtD
Cyclobenzaprine—Vomiting—Zoledronate—osteoporosis	0.000257	0.000767	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Estradiol—osteoporosis	0.000257	0.000766	CcSEcCtD
Cyclobenzaprine—Rash—Zoledronate—osteoporosis	0.000255	0.000761	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Estradiol—osteoporosis	0.000255	0.000761	CcSEcCtD
Cyclobenzaprine—Dermatitis—Zoledronate—osteoporosis	0.000255	0.00076	CcSEcCtD
Cyclobenzaprine—Headache—Zoledronate—osteoporosis	0.000253	0.000756	CcSEcCtD
Cyclobenzaprine—Vomiting—Conjugated Estrogens—osteoporosis	0.000248	0.000739	CcSEcCtD
Cyclobenzaprine—Urticaria—Estradiol—osteoporosis	0.000248	0.000739	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Estradiol—osteoporosis	0.000246	0.000735	CcSEcCtD
Cyclobenzaprine—Rash—Conjugated Estrogens—osteoporosis	0.000245	0.000733	CcSEcCtD
Cyclobenzaprine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000245	0.000732	CcSEcCtD
Cyclobenzaprine—Headache—Conjugated Estrogens—osteoporosis	0.000244	0.000728	CcSEcCtD
Cyclobenzaprine—Nausea—Zoledronate—osteoporosis	0.00024	0.000717	CcSEcCtD
Cyclobenzaprine—Nausea—Conjugated Estrogens—osteoporosis	0.000231	0.00069	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Estradiol—osteoporosis	0.00023	0.000685	CcSEcCtD
Cyclobenzaprine—Asthenia—Estradiol—osteoporosis	0.000224	0.000667	CcSEcCtD
Cyclobenzaprine—Pruritus—Estradiol—osteoporosis	0.00022	0.000658	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Estradiol—osteoporosis	0.000213	0.000636	CcSEcCtD
Cyclobenzaprine—Tamoxifen—ESR2—osteoporosis	0.000208	0.438	CrCbGaD
Cyclobenzaprine—Dizziness—Estradiol—osteoporosis	0.000206	0.000615	CcSEcCtD
Cyclobenzaprine—Vomiting—Estradiol—osteoporosis	0.000198	0.000591	CcSEcCtD
Cyclobenzaprine—Rash—Estradiol—osteoporosis	0.000196	0.000586	CcSEcCtD
Cyclobenzaprine—Dermatitis—Estradiol—osteoporosis	0.000196	0.000586	CcSEcCtD
Cyclobenzaprine—Headache—Estradiol—osteoporosis	0.000195	0.000583	CcSEcCtD
Cyclobenzaprine—Nausea—Estradiol—osteoporosis	0.000185	0.000552	CcSEcCtD
Cyclobenzaprine—Tamoxifen—CYP19A1—osteoporosis	0.000139	0.293	CrCbGaD
Cyclobenzaprine—Tamoxifen—ESR1—osteoporosis	0.000128	0.27	CrCbGaD
